Clinical Trial Update: Different Regimen of Aprotinine(Trasylol) Administration in Patients Receiving Antiplatelet Therapy With Clopidogrel (Plavix) [NA]

View source ↗

Summary

Clinical trial update on a different regimen of aprotinin (Trasylol) administration in patients receiving clopidogrel (Plavix) for coronary artery disease. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Plavix (clopidogrel)
• Trasylol (aprotinin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Coronary Artery Disease | NA | Status: COMPLETED